作者: Joyce G. Habib , Hatem A. Azim
DOI: 10.1007/978-3-319-17278-1_2
关键词: Oncology 、 Patient population 、 Ovarian Ablation 、 Medicine 、 Breast cancer subtype 、 Tumor biology 、 Breast cancer 、 Advanced disease 、 Internal medicine
摘要: Management of young patients with breast cancer still poses challenge to clinicians. Higher occurrence aggressive intrinsic subtypes and clinically advanced disease at diagnosis are observed in this patient population. Yet, they do not provide a full explanation for the poor clinical outcome younger patients. Increasingly, role tumor biology, irrespective underlying subtype, is being recognized as predictor worse